Does UCP2 Couple Hyperoxia to Lung Injury?

Jennifer L Larson-Casey,A Brent Carter,Jennifer L. Larson-Casey,A. Brent Carter
DOI: https://doi.org/10.1165/rcmb.2021-0480ED
IF: 7.748
2022-03-02
American Journal of Respiratory Cell and Molecular Biology
Abstract:First described for acute care treatment in 1885, supplemental inspired oxygen is routinely administered in critically ill patients to prevent or reverse hypoxemia. More recently, high levels of oxygen have been required in patients with severe cases of coronavirus disease (COVID-19). The obvious benefits of oxygen therapy, however, may be accompanied with complications when administered for prolonged periods at high concentrations. The untoward side effects of excessive oxygen administration include inflammatory cytokine production, atelectasis, coronary vasoconstriction, central nervous system toxicity, and several pulmonary disorders, including bronchopulmonary dysplasia in newborns, acute lung injury, and lung fibrosis (1). Recent data indicate an increase in mortality in patients experiencing hyperoxia in intensive care units (ICUs) (1, 2).
biochemistry & molecular biology,cell biology,respiratory system
What problem does this paper attempt to address?